Glutathione S-transferase T1 and M1 null genotypes and Parkinson’s disease risk: evidence from an updated meta-analysis

详细信息    查看全文

• 作者：Hongzhou Liu ; Jie Peng ; Jiajia Gao ; Fang Zheng ; Chaorong Tie
• 关键词：Glutathione S ; transferase T1 ; Glutathione S ; transferase M1 ; Polymorphism ; Parkinson’s disease
• 刊名：Neurological Sciences
• 出版年：2015
• 出版时间：September 2015
• 年：2015
• 卷：36
• 期：9
• 页码：1559-1565
• 全文大小：404 KB
• 参考文献：1.Dennis JC, Daniel KC (2004) Genetics and Parkinson’s disease. J Clin Neurosci 11:119-23CrossRef
  2.Pinhel MA, Sado CL, Longo Gdos S, Gregório ML, Amorim GS, Florim GM et al (2013) Nullity of GSTT1/GSTM1 related to pesticides is associated with Parkinson’s disease. Arq Neuropsiquiatr 71:527-32CrossRef PubMed
  3.Wahner AD, Glatt CE, Bronstein JM, Ritz B (2007) Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson’s disease. Neurosci Lett 413:274-78PubMed Central CrossRef PubMed
  4.Cornetta T, Patrono C, Terrenato I, De Nigris F, Bentivoglio AR, Testa A et al (2013) Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione S-transferase and DNA repair gene polymorphisms. Cell Mol Neurobiol 33:673-80CrossRef PubMed
  5.Stroombergen MC, Waring RH (1999) Determination of GST mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 18:141-45CrossRef PubMed
  6.De Palma G, Mozzoni P, Mutti A, Calzetti S, Negrotti A (1998) Case-control study of interactions between genetic and environmental factors in Parkinson’s disease. Lancet 352:1986-987CrossRef PubMed
  7.Perez-Pastene C, Graumann R, Diaz-Grez F, Miranda M, Venegas P, Godoy OT et al (2007) Association of GST M1 null polymorphism with Parkinson’s disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett 418:181-85CrossRef PubMed
  8.Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K et al (2010) GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population. Parkinsonism Relat Disord 16:447-52CrossRef PubMed
  9.Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T et al (2003) Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson’s disease. Neurosci Lett 337:5-CrossRef PubMed
  10.Jenner P, Olanow CW (1998) Understanding cell death in Parkinson’s disease. Ann Neurol 44:S72–S84CrossRef PubMed
  11.Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-71CrossRef PubMed
  12.Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904-911CrossRef PubMed
  13.Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B (1997) Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 324:25-8PubMed Central CrossRef PubMed
  14.Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300(Pt 1):271-76PubMed Central CrossRef PubMed
  15.Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M et al (2012) Genetic modification of the association of paraquat and Parkinson’s disease. Mov Disord 27:1652-658PubMed Central CrossRef PubMed
  16.De Palma G, Dick FD, Calzetti S, Scott NW, Prescott GJ, Osborne A et al (2010) A case-control study of Parkinson’s disease and tobacco use: gene-tobacco interactions. Mov Disord 25:912-19CrossRef PubMed
  17.Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D (2008) Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 312:131-38CrossRef PubMed
  18.Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ et al (2007) Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study. Occup Environ Med 64:673-80PubMed Central CrossRef PubMed
  19.Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T (2000) Variability and validity of polymorphism association studies in Parkinson’s disease. Neurology 55:533-38CrossRef PubMed
  20.Rahbar A, Kempkes M, Müller T, Reich S, Welter FL, Meves S et al (2000) Glutathione S-transferase polymorphism in Parkinson’s disease. J Neural Transm 107:331-34CrossRef PubMed
  21.Ahmadi A, Fredrikson M, Jerregard H, Akerb?ck A, Fall PA, Rannug A et al (2000) GSTM1 and mEPHX polymorphisms in Parkinson’s disease and age of onset. Biochem Biophys Res Commun 269:676-80CrossRef PubMed
  22.Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG (1998) Parkinson’s disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344-346CrossRef PubMed
  23.Vilar R, Coelho H, Rodrigues E, Gama MJ, Rivera I, Taioli E et al (2007) Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson’s disease. Eur J Neurol 14:156-61CrossRef PubMed
  24.Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD (2004) Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson’s disease. Neurosci Lett
• 作者单位：Hongzhou Liu (1)
  Jie Peng (2) (3)
  Jiajia Gao (1)
  Fang Zheng (1)
  Chaorong Tie (2)
  
  1. Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, 430071, People’s Republic of China
  2. Department of Stomatology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, People’s Republic of China
  3. Department of Stomatology, Wuhan Women and Children Medical Care Center, Wuhan, 430071, People’s Republic of China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Neurology
  Neuroradiology
  Neurosurgery
  Psychiatry
  
• 出版者：Springer Milan
• ISSN：1590-3478

文摘

Glutathione S-transferase T1 and M1 (GSTT1 and GSTM1) have been reported to be associated with Parkinson’s disease (PD). However, the results of these previous studies were inconsistent. The reported studies were conducted from 1990 to 2014 by searching PubMed. The total Odds Ratio and 95 % Confidence Interval were calculated and analyzed by Review Manager 5.1 and STATA 12. We also did subgroup analysis of ethnicity, publication year and sample size of total cases. Sensitivity analysis and publication bias were also done to evaluate the credibility of the results. A total of 3753 PD patients and 5636 controls from 19 case–control studies were identified. Overall, no association was observed (OR 1.01, 95 % CI 0.99-.21, P = 0.07) between GSTM1 null genotype and PD. There was significant association in Caucasians when subgroup analysis of ethnicity was performed, and the same conclusion was observed in European and UK. And it was also in publication year of 1995-999 and in sample size of total cases of <90 and 91-81. However, there was no significant association between GSTT1 null genotype and PD risk in this meta-analysis. Publication bias was negligible and the overall results were stable by sensitivity analysis. A slight increase of PD risk was detected in the meta-analysis of GSTM1 null genotype in subgroup analysis of ethnicity, publication year and sample size of total cases. However, short of statistical significance was detected for GSTT1 null genotype. Keywords Glutathione S-transferase T1 Glutathione S-transferase M1 Polymorphism Parkinson’s disease